Impact of Disease Recurrence and Outcomes following Kidney Transplantation for GN
Kidney360 · 2026-09 · 7 (9) · 2102-2113
DOI: 10.34067/kid.0000001218 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney360, online erschienen am 13.05.2026. Verfasst von Matthieu Halfon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Medicine and Surgery, Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland. Hauptthemen laut MEDLINE: Kidney Transplantation, Graft Rejection, Glomerulonephritis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Key Points GN is one of the main causes of kidney transplantation. In patients transplanted for GN, the risk of recurrence is approximately 16%. Recurrence significantly worsens the prognostic, tripling and doubling the risk of graft loss and acute rejection, respectively. Despite having more often received immunosuppression before transplantation, patients with GN are not at increased risk of post-transplantation cancers.
Background
Patients who receive transplants after kidney failure due to GN (GN-KTx) constitute a significant portion of recipients and may face unique challenges post-transplantation, related to the risk of GN recurrence and a higher global burden of immunosuppression.
Methods
We analyzed patient and graft outcomes, including the risk of graft loss in relation to recurrence in GN-KTx, compared with patients transplanted for other causes, using data from the prospective nationwide Swiss Transplant Cohort Study.
Results
Among 2631 included patients, 701 were GN-KTx, with IgA nephropathy being the most common GN subtype. GN-KTx recipients were younger and more likely to receive living donor organs. During a mean follow-up period of 5.3 years (interquartile range, 2.3–8.2), the 5-year cumulative incidence of graft loss was similar across groups, with GN-KTx at 6%. Notably, GN-KTx had a similar incidence of acute rejection as other groups. Recurrence occurred in 16% of GN-KTx within a mean time of 1.7 years (interquartile range, 0.28–2). Patients with recurrence faced a three-fold higher risk of graft loss. Furthermore, disease recurrence was associated with a two-fold higher risk of acute rejection compared with nonrecurrent GN-KTx. Interestingly, regarding cancer risks, GN-KTx patients had the lowest incidence of skin cancer and no higher risk of nonskin cancers, despite greater exposure to immunosuppression compared with other kidney transplant recipients.
Conclusions
These real-life setting contemporary multicenter data highlight the importance of post-transplant monitoring for GN recurrence, given the strong association with poor graft outcomes and higher rejection rates. This is important in the context of current development of targeted therapies for GN in native kidneys that could be transposed to transplanted kidneys.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departments of Medicine and Surgery, Transplantation Center, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
- Division of Biostatistics, University Center for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.
- Division of Nephrology and Transplantation Medicine, HOCH Cantonal Hospital St. Gallen, St. Gallen, Switzerland.
- Department of Surgery, Service of Transplantation, Geneva University Hospitals, University of Geneva, Geneva, Switzerland.
- Department of Nephrology and Hypertension, Inselspital University Hospital Bern, University of Bern, Bern, Switzerland.
- Division of Nephrology, University Hospital Zürich, Zürich, Switzerland.
ORCID-Profile: Patrick Taffé, Christian Bucher, Laila-Yasmin Mani, Thomas Schachtner, Caroline Wehmeier, Fadi Fakhouri, Dela Golshayan
Zitieren
APA
Halfon, M., Taffé, P., Bucher, C., Haidar, F., Huynh-do, U., Mani, L. Y., Schachtner, T., Wehmeier, C., Venetz, J. P., Pascual, M., Fakhouri, F., Golshayan, D., & Swiss Transplant Cohort Study (STCS) (2026). Impact of Disease Recurrence and Outcomes following Kidney Transplantation for GN. Kidney360, 7(9), 2102-2113. https://doi.org/10.34067/kid.0000001218
Vancouver
Halfon M, Taffé P, Bucher C, Haidar F, Huynh-do U, Mani LY, et al. Impact of Disease Recurrence and Outcomes following Kidney Transplantation for GN. Kidney360. 2026;7(9):2102-2113. doi:10.34067/kid.0000001218
BibTeX
@article{Halfon2026,
author = {Halfon, Matthieu and Taffé, Patrick and Bucher, Christian and Haidar, Fadi and Huynh-do, Uyen and Mani, Laila-Yasmin and Schachtner, Thomas and Wehmeier, Caroline and Venetz, Jean-Pierre and Pascual, Manuel and Fakhouri, Fadi and Golshayan, Dela and Swiss Transplant Cohort Study (STCS), Swiss Transplant Cohort Study (STCS)},
title = {Impact of Disease Recurrence and Outcomes following Kidney Transplantation for GN},
journal = {Kidney360},
year = {2026},
volume = {7},
number = {9},
pages = {2102--2113},
doi = {10.34067/kid.0000001218}
}
EUVIMED